News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Facet Biotech Chief Business Officer “Terminated”
January 7, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
January 6, 2009 - San Francisco Business Times - Redwood City’s Facet Biotech Corp. — recently spun off from PDL BioPharma Inc. — will part with its chief business officer Friday.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Artificial intelligence
Merck adds to biopharma’s AI agenda with up to $510M+ Protillion pact
June 17, 2026
·
2 min read
·
Tristan Manalac
Podcast
Moderna’s FDA adcomm, IPO mania, biopharma layoffs, more
June 17, 2026
·
2 min read
·
Jef Akst
Layoff Tracker
Neumora, enGene cut staff in cost-saving initiatives
June 16, 2026
·
61 min read
·
BioSpace Editorial Staff
Drug Development
Neumora discards depression asset, lays off staffers after pair of late-stage flops
June 15, 2026
·
2 min read
·
Gabrielle Masson
